learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes
Vous n'êtes pas connecté
Glucagon-like peptide-1 (GLP-1) receptor agonists are increasingly used in the treatment of medlinktype 2 diabetes/medlink and medlinkobesity/medlink.
learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes
learn about suicide and self-harm risks among users of GLP-1 receptor agonists for type 2 diabetes, obesity, and mental health outcomes
When we discuss heart health for people with type 2 diabetes, the conversation often goes beyond the typical advice of improving diet and exercise. A...
When we discuss heart health for people with type 2 diabetes, the conversation often goes beyond the typical advice of improving diet and exercise. A...
Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a newer class of drugs used to manage diabetes, have recently been linked to a rare but serious...
The province of BC says they're going to step up and secure treatment within the correctional system for people who need mental health and...
The province of BC says they're going to step up and secure treatment within the correctional system for people who need mental health and...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...
Recent research from scientists at Northwestern University has brought to light serious concerns about the safety of two widely prescribed drugs for...